BIOMAT Database Logo BIOMAT Database Logo

[Early results of treatment of patients with chronic pulmonary tuberculosis with rifampicin]. 1974

M Böszörmenyi

UI MeSH Term Description Entries
D008297 Male Males
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

M Böszörmenyi
[Late results of treatment of chronic pulmonary tuberculosis with rifampicin].
July 1973, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
M Böszörmenyi
[Early results of rifampicin treatment combined with other antitubercular agents in patients with recent and chronic pulmonary tuberculosis].
February 1979, Pneumonologia polska,
M Böszörmenyi
[Long-term results of treatment with rifampicin in early pulmonary tuberculosis].
January 1972, Archivio Monaldi per la tisiologia e le malattie dell'apparato respiratorio,
M Böszörmenyi
[Delayed results of treatment of pulmonary tuberculosis with rifampicin].
May 1974, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
M Böszörmenyi
[Preliminary results of treatment of pulmonary tuberculosis with rifampicin].
January 1969, Giornale italiano delle malattie del torace,
M Böszörmenyi
[Immediate results of strictly supervised, intermittent treatment with rifampicin and ethambutol in patients with chronic pulmonary tuberculosis].
January 1977, Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia,
M Böszörmenyi
[Rifampicin in the treatment of chronic pulmonary tuberculosis].
June 1976, Gaceta medica de Mexico,
M Böszörmenyi
[Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].
July 1972, Revista clinica espanola,
M Böszörmenyi
[Treatment of chronic destructive pulmonary tuberculosis with rifampicin and ethambutol].
January 1971, Problemy tuberkuleza,
M Böszörmenyi
[Treatment of pulmonary tuberculosis with rifampicin].
March 1969, Revue de tuberculose et de pneumologie,
Copied contents to your clipboard!